Baroldi Joseph, EVP and Chief Business Officer at Ionis Pharmaceuticals ($IONS), sold about $5.5 million in company shares across 15 open market transactions over the past year. His most recent sale occurred on March 4, 2026. These sales rank him 1,794th among 11,678 insiders by total value sold, below the average of $8.6 million per insider and 6.4 transactions. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Non-Qualified Stock Option (right to buy) | 820 | $0.00 | 4,104.0000 | 158,964,772 | 16.65% | 0.00% |
| March 4, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Non-Qualified Stock Option (right to buy) | 201 | $0.00 | 1,769.0000 | 158,964,772 | 10.20% | 0.00% |
| March 3, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Non-Qualified Stock Option (right to buy) | 879 | $0.00 | 1,970.0000 | 158,964,772 | 30.85% | 0.00% |
| March 4, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | S | Common Stock | 201 | $80.00 | 45,664.0000 | 158,964,772 | 0.44% | 0.00% |
| March 4, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Common Stock | 201 | $32.60 | 45,865.0000 | 158,964,772 | 0.44% | 0.00% |
| March 4, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | S | Common Stock | 238 | $80.00 | 45,664.0000 | 158,964,772 | 0.52% | 0.00% |
| March 4, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Common Stock | 238 | $56.78 | 45,902.0000 | 158,964,772 | 0.52% | 0.00% |
| March 3, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | S | Common Stock | 36 | $81.01 | 45,664.0000 | 158,964,772 | 0.08% | 0.00% |
| March 3, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | S | Common Stock | 2088 | $80.41 | 45,700.0000 | 158,964,772 | 4.37% | 0.00% |
| March 3, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Common Stock | 879 | $32.60 | 47,788.0000 | 158,964,772 | 1.87% | 0.00% |
| March 3, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Common Stock | 820 | $56.78 | 46,909.0000 | 158,964,772 | 1.78% | 0.00% |
| March 3, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | S | Common Stock | 4096 | $79.36 | 45,664.0000 | 158,964,772 | 8.23% | 0.00% |
| March 4, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Non-Qualified Stock Option (right to buy) | 238 | $0.00 | 3,866.0000 | 158,964,772 | 5.80% | 0.00% |
| Jan. 30, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | S | Common Stock | 5296 | $82.96 | 50,185.0000 | 158,964,772 | 9.55% | 0.00% |
| Jan. 29, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | A | Common Stock | 10278 | $0.00 | 55,481.0000 | 158,964,772 | 22.74% | 0.01% |
| Jan. 15, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Restricted Stock Unit | 2850 | $0.00 | 64,623.0000 | 158,964,772 | 4.22% | 0.00% |
| Jan. 15, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | A | Restricted Stock Unit | 9675 | $0.00 | 68,523.0000 | 158,964,772 | 16.44% | 0.01% |
| Jan. 15, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Restricted Stock Unit | 17037 | $0.00 | 58,848.0000 | 158,964,772 | 22.45% | 0.01% |
| Jan. 15, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | A | Performance Restricted Stock Units | 25800 | $0.00 | 77,090.0000 | 158,964,772 | 50.30% | 0.02% |
| Jan. 16, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | S | Common Stock | 1149 | $75.78 | 45,203.0000 | 158,964,772 | 2.48% | 0.00% |
| Jan. 15, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Common Stock | 2850 | $0.00 | 46,352.0000 | 158,964,772 | 6.55% | 0.00% |
| Jan. 15, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Common Stock | 17037 | $0.00 | 52,110.0000 | 158,964,772 | 48.58% | 0.01% |
| Jan. 16, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | S | Common Stock | 6907 | $75.75 | 45,203.0000 | 158,964,772 | 13.25% | 0.00% |
| Jan. 15, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | A | Restricted Stock Unit | 3900 | $0.00 | 68,523.0000 | 158,964,772 | 6.04% | 0.00% |
| Jan. 2, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | A | Non-Qualified Stock Option (right to buy) | 19350 | $0.00 | 21,950.0000 | 158,964,772 | 744.23% | 0.01% |
| Jan. 2, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | A | Non-Qualified Stock Option (right to buy) | 2600 | $0.00 | 21,950.0000 | 158,964,772 | 13.44% | 0.00% |
| Oct. 6, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | S | Common Stock | 1625 | $69.37 | 33,372.0000 | 158,964,772 | 4.64% | 0.00% |
| Oct. 2, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | S | Common Stock | 15000 | $68.01 | 34,997.0000 | 158,964,772 | 30.00% | 0.01% |
| Oct. 2, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Non-Qualified Stock Option (right to buy) | 15000 | $0.00 | 26,700.0000 | 158,964,772 | 35.97% | 0.01% |
| Oct. 2, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Common Stock | 15000 | $31.80 | 49,997.0000 | 158,964,772 | 42.86% | 0.01% |
| Sept. 9, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | S | Common Stock | 11950 | $62.16 | 34,997.0000 | 158,964,772 | 25.45% | 0.01% |
| Sept. 9, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Common Stock | 11950 | $31.80 | 46,947.0000 | 158,964,772 | 34.15% | 0.01% |
| Sept. 9, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Non-Qualified Stock Option (right to buy) | 11950 | $0.00 | 41,700.0000 | 158,964,772 | 22.27% | 0.01% |
| Sept. 5, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | S | Common Stock | 250 | $62.00 | 34,997.0000 | 158,964,772 | 0.71% | 0.00% |
| Sept. 5, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Common Stock | 250 | $31.80 | 35,247.0000 | 158,964,772 | 0.71% | 0.00% |
| Sept. 5, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Non-Qualified Stock Option (right to buy) | 250 | $0.00 | 53,650.0000 | 158,964,772 | 0.46% | 0.00% |
| Sept. 3, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Non-Qualified Stock Option (right to buy) | 15000 | $0.00 | 53,900.0000 | 158,964,772 | 21.77% | 0.01% |
| Sept. 3, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Common Stock | 2800 | $31.80 | 37,797.0000 | 158,964,772 | 8.00% | 0.00% |
| Sept. 3, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | S | Common Stock | 2800 | $62.01 | 34,997.0000 | 158,964,772 | 7.41% | 0.00% |
| Sept. 3, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Common Stock | 15000 | $31.80 | 49,997.0000 | 158,964,772 | 42.86% | 0.01% |
| Sept. 3, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | S | Common Stock | 30000 | $59.09 | 19,997.0000 | 158,964,772 | 60.00% | 0.02% |
| Sept. 3, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Common Stock | 15000 | $31.80 | 34,997.0000 | 158,964,772 | 75.01% | 0.01% |
| Sept. 3, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Non-Qualified Stock Option (right to buy) | 2800 | $0.00 | 83,900.0000 | 158,964,772 | 3.23% | 0.00% |
| Sept. 3, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Non-Qualified Stock Option (right to buy) | 15000 | $0.00 | 68,900.0000 | 158,964,772 | 17.88% | 0.01% |
| April 15, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Common Stock | 10837 | $0.00 | 38,925.0000 | 158,964,772 | 38.58% | 0.01% |
| April 16, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | S | Common Stock | 3928 | $28.40 | 34,997.0000 | 158,964,772 | 10.09% | 0.00% |
| April 15, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Restricted Stock Unit | 10837 | $0.00 | 66,511.0000 | 158,964,772 | 14.01% | 0.01% |
| Jan. 15, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Common Stock | 8787 | $0.00 | 31,489.0000 | 0 | 38.71% | 0.00% |
| Jan. 16, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | S | Common Stock | 3401 | $32.70 | 28,088.0000 | 0 | 10.80% | 0.00% |
| Jan. 15, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Common Stock | 2460 | $0.00 | 29,117.0000 | 0 | 9.23% | 0.00% |
| Jan. 16, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | S | Common Stock | 1029 | $32.70 | 28,088.0000 | 0 | 3.53% | 0.00% |
| Jan. 15, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | A | Performance Restricted Stock Units | 22000 | $0.00 | 51,290.0000 | 0 | 75.11% | 0.00% |
| Jan. 15, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | A | Restricted Stock Unit | 33000 | $0.00 | 94,459.0000 | 0 | 53.69% | 0.00% |
| Jan. 15, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Restricted Stock Unit | 8787 | $0.00 | 85,672.0000 | 0 | 9.30% | 0.00% |
| Jan. 15, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | A | Restricted Stock Unit | 3750 | $0.00 | 88,132.0000 | 0 | 4.44% | 0.00% |
| Jan. 15, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Restricted Stock Unit | 2460 | $0.00 | 85,672.0000 | 0 | 2.79% | 0.00% |
| Jan. 2, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | A | Non-Qualified Stock Option (right to buy) | 22000 | $0.00 | 24,500.0000 | 0 | 880.00% | 0.00% |
| Jan. 2, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | A | Non-Qualified Stock Option (right to buy) | 2500 | $0.00 | 24,500.0000 | 0 | 11.36% | 0.00% |
| April 15, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Common Stock | 10838 | $0.00 | 25,277.0000 | 0 | 75.06% | 0.00% |
| April 16, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | S | Common Stock | 4006 | $41.60 | 21,271.0000 | 0 | 15.85% | 0.00% |
| April 15, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Restricted Stock Unit | 10838 | $0.00 | 53,135.0000 | 0 | 16.94% | 0.00% |
| Jan. 16, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Restricted Stock Unit | 3688 | $0.00 | 71,007.0000 | 0 | 4.94% | 0.00% |
| Jan. 16, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Restricted Stock Unit | 1353 | $0.00 | 71,007.0000 | 0 | 1.87% | 0.00% |
| Jan. 17, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | S | Common Stock | 564 | $50.42 | 14,439.0000 | 0 | 3.76% | 0.00% |
| Jan. 16, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Common Stock | 1353 | $0.00 | 15,003.0000 | 0 | 9.91% | 0.00% |
| Jan. 17, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | S | Common Stock | 1460 | $50.42 | 14,439.0000 | 0 | 9.18% | 0.00% |
| Jan. 16, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Common Stock | 3688 | $0.00 | 15,899.0000 | 0 | 30.20% | 0.00% |
| Jan. 15, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | A | Performance Restricted Stock Units | 17000 | $0.00 | 29,290.0000 | 0 | 138.32% | 0.00% |
| Jan. 15, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | A | Restricted Stock Unit | 1800 | $0.00 | 73,423.0000 | 0 | 2.51% | 0.00% |
| Jan. 15, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | A | Restricted Stock Unit | 2625 | $0.00 | 76,048.0000 | 0 | 3.58% | 0.00% |
| Jan. 15, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | A | Restricted Stock Unit | 20400 | $0.00 | 76,048.0000 | 0 | 36.66% | 0.00% |
| Jan. 2, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | A | Non-Qualified Stock Option (right to buy) | 3500 | $0.00 | 30,700.0000 | 0 | 12.87% | 0.00% |
| Jan. 2, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | A | Non-Qualified Stock Option (right to buy) | 27200 | $0.00 | 30,700.0000 | 0 | 777.14% | 0.00% |
| Oct. 1, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | A | Non-Qualified Stock Option (right to buy) | 2400 | $0.00 | 2,400.0000 | 0 | 9999.99% | 0.00% |
| April 18, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | S | Common Stock | 3880 | $36.50 | 11,422.0000 | 0 | 25.36% | 0.00% |
| April 17, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Common Stock | 10838 | $0.00 | 15,302.0000 | 0 | 242.79% | 0.00% |
| April 17, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Restricted Stock Unit | 10838 | $0.00 | 47,261.0000 | 0 | 18.65% | 0.00% |
| Jan. 17, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Restricted Stock Unit | 904 | $0.00 | 3,962.0000 | 0 | 18.58% | 0.00% |
| Jan. 18, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | S | Common Stock | 375 | $39.79 | 4,464.0000 | 0 | 7.75% | 0.00% |
| Jan. 17, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | M | Common Stock | 904 | $0.00 | 4,839.0000 | 0 | 22.97% | 0.00% |
| Jan. 15, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | A | Restricted Stock Unit | 14749 | $0.00 | 62,965.0000 | 0 | 30.59% | 0.00% |
| Jan. 15, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | A | Performance Restricted Stock Units | 12290 | $0.00 | 12,290.0000 | 0 | 9999.99% | 0.00% |
| Jan. 15, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | A | Restricted Stock Unit | 1800 | $0.00 | 62,965.0000 | 0 | 2.94% | 0.00% |
| Jan. 3, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | A | Non-Qualified Stock Option (right to buy) | 19665 | $0.00 | 22,065.0000 | 0 | 819.38% | 0.00% |
| Jan. 3, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Baroldi Joseph | EVP, Chief Business Officer | A | Non-Qualified Stock Option (right to buy) | 2400 | $0.00 | 22,065.0000 | 0 | 12.20% | 0.00% |